HPV Vaccination Not Tied to Risky Sexual Behavior in Teen Girls
THURSDAY, Oct. 18, 2018 -- Implementation of a school-based human papillomavirus (HPV) vaccination program in Canada did not lead to an increase in sexual risk-taking behaviors among adolescent girls, according to a study published in the Oct. 15... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 18, 2018 Category: Pharmaceuticals Source Type: news

HPV vaccination not linked with rise in teen risky sex
(Reuters Health) - A new study adds to earlier evidence that getting vaccinated against the human papillomavirus (HPV) does not lead girls to be less careful about sex. (Source: Reuters: Health)
Source: Reuters: Health - October 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

HVP vaccination not linked with rise in teen risky sex
(Reuters Health) - A new study adds to earlier evidence that getting vaccinated against the human papillomavirus (HPV) does not lead girls to be less careful about sex. (Source: Reuters: Health)
Source: Reuters: Health - October 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Preteens' HPV Shot Won't Encourage Early Sex, Study Says
MONDAY, Oct. 15, 2018 -- Despite some parents'fears, girls who get vaccinated against human papillomavirus (HPV) do not see it as permission to have sex, a new study finds. HPV is a sexually transmitted infection that can cause genital warts and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 15, 2018 Category: General Medicine Source Type: news

12-year-old girl becomes paralyzed after being injected with Gardasil... doctors say it's all in her mind
(Natural News) Vaccines are heralded as “life-saving” medicine, but for Mia Blesky, that’s anything but true. The preteen from England was given the first round of the Gardasil shot at school when she was just 12 years old, and life has never been the same ever since. Within just 24 hours, Mia’s Gardasil nightmare was... (Source: NaturalNews.com)
Source: NaturalNews.com - October 11, 2018 Category: Consumer Health News Source Type: news

La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 a ños de edad
La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 a ños de edad (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 9, 2018 Category: American Health Source Type: news

La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 a ñ os de edad
La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 a ñ os de edad (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 9, 2018 Category: American Health Source Type: news

FDA Approves HPV Vaccine for People Through Age 45
TUESDAY, Oct. 9, 2018 -- U.S. Food and Drug Administration approval of the Gardasil 9 human papillomavirus (HPV) vaccine has been expanded to include people ages 27 through 45, the agency said in a news release. Gardasil 9, approved in 2014 for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 9, 2018 Category: Pharmaceuticals Source Type: news

HPV Vaccine Approved for People Through Age 45
TUESDAY, Oct. 9, 2018 -- U.S. Food and Drug Administration approval of the Gardasil 9 human papillomavirus (HPV) vaccine has been expanded to include people ages 27 through 45, the agency said in a news release. Gardasil 9, approved in 2014 for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 9, 2018 Category: General Medicine Source Type: news

FDA Expands Gardasil to Cover Adults to Age 45
About 14 million Americans become infected with HPV every year, the CDC says. About 12,000 women are diagnosed with cervical cancer and about 4,000 women die from cervical cancer caused by certain HPV viruses. (Source: WebMD Health)
Source: WebMD Health - October 8, 2018 Category: Consumer Health News Source Type: news

FDA expands use of HPV vaccine for older men, women
The U.S. Food and Drug Administration has expanded the use of Gardasil 9 -- a vaccine for HPV -- to include women and men age 27 through 45. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 8, 2018 Category: Consumer Health News Source Type: news

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
The U.S. Food and Drug Administration approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine. (Source: World Pharma News)
Source: World Pharma News - October 8, 2018 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA Expands Gardasil to Cover Adults to Age 45
Title: FDA Expands Gardasil to Cover Adults to Age 45Category: Health NewsCreated: 10/8/2018 12:00:00 AMLast Editorial Review: 10/8/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - October 8, 2018 Category: Cancer & Oncology Source Type: news

FDA Expands Gardasil to Cover Adults to Age 45
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 8, 2018 Category: General Medicine Source Type: news

FDA expands use of HPV vaccine to adults 27 to 45
The FDA approved the HPV vaccine Gardasil 9 for use in adults ages 27 to 45 after studies showed it provided protection against genital warts and certain cancers. (Source: CNN.com - Health)
Source: CNN.com - Health - October 6, 2018 Category: Consumer Health News Source Type: news

HPV Vaccine Expanded for People Ages 27 to 45
The Food and Drug Administration has approved the use of Gardasil 9, a vaccine against nine strains of the human papillomavirus for older age groups. (Source: NYT Health)
Source: NYT Health - October 5, 2018 Category: Consumer Health News Authors: DENISE GRADY and JAN HOFFMAN Tags: Human Papillomavirus (HPV) Gardasil (Vaccine) Vaccination and Immunization Sexually Transmitted Diseases Food and Drug Administration Merck & Company Inc Cancer Source Type: news

FDA Expands Gardasil to Include Adults Up to Age 45 FDA Expands Gardasil to Include Adults Up to Age 45
The expanded age range for Gardasil 9 is an important opportunity to help prevent HPV-related diseases and cancers in a broader age range, the FDA said.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 5, 2018 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

Adults Up to Age 45 Can Now Get the HPV Vaccine
Adults up to age 45 can now be vaccinated against human papillomavirus (HPV), reducing their chances of getting cervical, oral and other cancers. The Food and Drug Administration (FDA) announced Friday that Gardasil 9, a vaccine that works against nine different types of HPV, is now approved for both men and women between the ages of 27 and 45. Previously, it was approved only for those between the ages of nine and 26, and recommended for all children at age 11 or 12. “Today’s approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” Dr. Peter M...
Source: TIME: Health - October 5, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 Through 45 Years Old
October 5, 2018 -- The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 5, 2018 Category: Drugs & Pharmacology Source Type: news

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
(Source: Food and Drug Administration)
Source: Food and Drug Administration - October 5, 2018 Category: American Health Source Type: news

More Than 14 Million Preteens Need to Receive HPV Vaccine
FRIDAY, Oct. 5, 2018 -- More than 14 million additional 11- to 12-year-olds need to be vaccinated to reach the American Cancer Society goal of 80 percent of adolescents being up to date (UTD) with the human papillomavirus vaccination (HPVV) by their... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2018 Category: Pharmaceuticals Source Type: news

More Preteens Need HPV Shots to Meet Public Health Goal
THURSDAY, Oct. 4, 2018 -- Current rates of human papillomavirus (HPV) vaccination among preteens are too low to achieve goals set by the American Cancer Society, according to a new study. The cancer society wants an 80 percent vaccination rate... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 4, 2018 Category: General Medicine Source Type: news

Nearly 14 million additional adolescents need HPV vaccination to reach public health goal
(American Cancer Society) Nearly 14 million additional adolescents will need to receive the human papillomavirus (HPV) vaccine to reach the American Cancer Society's goal of an 80 percent vaccination rate by that 2026. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 2, 2018 Category: Infectious Diseases Source Type: news

DNA vaccine leads to immune responses in HPV-related head and neck cancer
(University of Pennsylvania School of Medicine) A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center of the University of Pennsylvania tested the immunotherapy approach in two groups of patients with advanced head and neck squamous cell carcinoma (HNSCCa) and found 86 percent showed elevated T cell activity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 21, 2018 Category: Cancer & Oncology Source Type: news

Analysis finds HPV vaccine safe
(Wiley) Infection with human papillomavirus (HPV) can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types. A new British Journal of Clinical Pharmacology review of post-licensure data did not identify any new or unexpected safety concerns of the bivalent HPV vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 19, 2018 Category: International Medicine & Public Health Source Type: news

Gardasil is a deadly concoction that leads to permanent, devastating health effects
(Natural News) The topic of whether vaccines do more harm than good has been debated ad nauseam, but even some of those who tend to lean in favor of vaccination as a general concept are willing to admit that vaccines like Gardasil simply aren’t worth the risk. The Gardasil vaccine was developed to help prevent... (Source: NaturalNews.com)
Source: NaturalNews.com - September 18, 2018 Category: Consumer Health News Source Type: news

Cochrane Collaboration Expels Dr Peter G ø tzsche Cochrane Collaboration Expels Dr Peter G ø tzsche
His expulsion from the Cochrane Collaboration Governing Body comes shortly after he harshly criticized a Cochrane review of human papillomavirus vaccine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cochrane Board Expels Critic of Group's HPV Vaccine Review Cochrane Board Expels Critic of Group's HPV Vaccine Review
His expulsion from the Cochrane Collaboration Governing Body comes shortly after he harshly criticized a Cochrane review of human papillomavirus vaccine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cancer Will Kill About 10 Million People This Year, Experts Predict
Nearly 10 million people around the world will die of cancer this year, according to new estimates from the World Health Organization’s International Agency for Research on Cancer (IARC). The IARC’s report, which was published Wednesday in CA: A Cancer Journal for Clinicians, was based on cancer incidence data from 185 countries around the world. Researchers estimated that there will be 18.1 million new diagnoses of cancer and 9.6 million cancer deaths in 2018. Those numbers — a marked increase from just six years ago, when cancer diagnoses were estimated at 14.1 million, and deaths at 8.2 million —...
Source: TIME: Health - September 14, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Innovation Health Source Type: news

Africa:Stopping Cervical Cancer and Other Noncommunicable Diseases in Africa
[WHO] As she felt the cold sting of the needle enter her arm, Alice winced in fear more than pain- understandable as she is only 10. However, a moment of pain could save her from the leading cause of cancer death among women in Africa: cervical cancer. She is receiving a vaccine against human papilloma virus (HPV), the main gateway agent in cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 12, 2018 Category: African Health Source Type: news

HPV Vaccine May Reduce Risk Of Transmitting Devastating Throat Disease To Children
Human papillomavirus (HPV) of the female genital tract may infect the fetus, leading to a rare, yet severe respiratory disease in infants and children. Studies are underway to address the eradication of this disease by widespread use of the HPV vaccine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 5, 2018 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Source Type: news

Kenya:In Kenya, HPV Vaccine to Be Rolled Out Next Year
[East African] The national rollout of free Human Papillomavirus (HPV) vaccine in Kenya has been pushed to next year due to what an official termed high demand from countries across the globe. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 5, 2018 Category: African Health Source Type: news

CDC: HPV Vaccination Rates Increasing Among Adolescents
WEDNESDAY, Sept. 5, 2018 -- Human papillomavirus (HPV) vaccination coverage increased 5.1 percentage points from 2016 to 2017, and there was also an increase in the number of adolescents up to date with HPV vaccinations, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2018 Category: Pharmaceuticals Source Type: news

Requiring insurers to cover retail pharmacy vaccinations for adult Californians could save lives, study finds
Requiring health insurers to pay for adult vaccinations given at retail pharmacies could help prevent the spread of deadly communicable diseases such as influenza, pneumococcal infection and human papillomavirus, according to a  new study by the UCLA Center for Health Policy Research.Many insurers do not cover pharmacy-administered vaccines; cover a limited selection of vaccines; or require people they insure to get vaccinated only at pharmacies within their insurance network, the study reports.Overall vaccination rates in state are lowThe overall vaccination rate among adult Californians is far below federa...
Source: UCLA Newsroom: Health Sciences - August 30, 2018 Category: Universities & Medical Training Source Type: news

Vaccine tied to drop in HPV cases still not reaching half of U.S. kids
(Reuters Health) - Although a vaccine for the cancer-causing human papillomavirus (HPV) has led to a dramatic decrease in infections, a new study suggests that half of U.S. teens are still not fully vaccinated against this virus. (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Cochrane ’s Editor in Chief responds to BMJ EBM article criticizing HPV review
On 27th July 2018,an article was published in the journalBMJ Evidence-Based Medicine relating to therecently published Cochrane Review on prophylactic human papillomavirus (HPV) vaccines.  The article is based on analyses undertaken at the Nordic Cochrane Centre, and two of the authors are experienced Cochrane researchers: Professors Peter G øtzsche and Tom Jefferson. It made several criticisms of the Cochrane Review, most notable of which was that the Cochrane Review was incomplete due to missing " nearly half of the eligible trials " .Cochrane takes all criticisms and feedback seriously, seeing this...
Source: Cochrane News and Events - August 29, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Study: HPV Vaccine Doesn't Hurt Girls' Fertility
Investigators who studied nearly 200,000 young women said they found no elevated risk of premature menopause after recommended vaccinations, including for the human papillomavirus. (Source: WebMD Health)
Source: WebMD Health - August 24, 2018 Category: Consumer Health News Source Type: news

HPV-related cancer rises, despite higher vaccination rates
The number of cancer cases associated with the human papillomavirus (HPV) is growing even as an increasing number of adolescents are being vaccinated against HPV. According to the Centers for Disease Control and Prevention, more than 43,000 people developed HPV-associated cancer in 2015, compared with about 30,000 in 1999, STAT reports, with throat cancer now the most common HPV-related malignancy. But the CDC also reported that the percentage of adolescen ts receiving all the recommended doses… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 24, 2018 Category: American Health Authors: Anne Stych Source Type: news

HPV Vaccine Doesn't Put Girls' Fertility at Risk: Study
FRIDAY, Aug. 24, 2018 -- HPV vaccination does not hurt teen girls'future fertility, a new study says. Large studies have called the HPV (human papillomavirus) shot safe, but vaccination rates in the United States are lower than for other shots... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 24, 2018 Category: General Medicine Source Type: news

HPV Vaccination Rates Rising Among U.S. Teens
Nearly 66 percent of boys and girls aged 13 to 17 received the first dose in the HPV vaccine series in 2017, according to the U.S. Centers for Disease Control and Prevention researchers. And nearly 49 percent of adolescents received all the recommended doses to complete the series. The human papillomavirus (HPV) causes most cases of cervical cancer. (Source: WebMD Health)
Source: WebMD Health - August 23, 2018 Category: Consumer Health News Source Type: news

More Teenagers Than Ever Are Getting the HPV Vaccine, CDC Says
More teenagers than ever before are getting vaccinated against human papillomavirus (HPV), according to new data from the Centers for Disease Control and Prevention (CDC). Federal guidelines now say that all children should start two-dose HPV vaccination at age 11 or 12 to protect against HPV-associated cervical, vaginal, penile, anal and throat cancers. Despite that recommendation, however, HPV vaccination rates have traditionally lagged far below their targets. That’s still true — but the new report does suggest that rates are rising. Between 2016 and 2017, the CDC says, the percentage of teenagers who report...
Source: TIME: Health - August 23, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

Rise in HPV-related cancers DESPITE rise in vaccine coverage
In 2015, 43,000 Americans were diagnosed with a cancer related to the human papillomavirus - up from 30,000 in 1999. We may still be a few years off seeing the effects of the vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - August 23, 2018 Category: Consumer Health News Source Type: news

Addressing human papillomavirus prevention during pediatric acute sexual assault care - Deutsch SA, Benyo S, Xie S, Carlin E, Andalaro B, Clagg B, De Jong A.
BACKGROUND/OBJECTIVES: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. Pediatric sexual assault (SA) victims are a special population eligible for HPV vaccination at the age of 9 years. National clinical p... (Source: SafetyLit)
Source: SafetyLit - August 23, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Catch-Up HPV Doses Effective to Age 21 Against Cervical Neoplasia
WEDNESDAY, Aug. 22, 2018 -- Catch-up doses of quadrivalent human papillomavirus (HPV) vaccination are effective for girls and women aged 14 to 20 years at the time of first dose, according to a study published online Aug. 7 in The Lancet Child&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 22, 2018 Category: Pharmaceuticals Source Type: news

HPV Testing Can Replace Pap Smears for Many Women, New Guidelines Say
Pap smears, long the gold standard for cervical cancer screening, may be used less frequently under new guidelines from the U.S. Preventive Services Task Force. The recommendations, which were published Tuesday in JAMA, say that women between ages 30 and 65 can rely on human papillomavirus (HPV) testing instead of, or in addition to, Pap smears. Women in this age group should get HPV testing every five years, a Pap smear every three years or a combination of the two tests every five years, the guidelines say. HPV causes the vast majority of cervical cancer cases, according to the National Cancer Institute, which makes HPV ...
Source: TIME: Health - August 21, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer healthytime Innovation Health onetime Source Type: news

Large study finds HPV vaccination does not negatively impact fertility in adolescents
(Kaiser Permanente) Adolescents who receive recommended vaccinations, including for human papillomavirus, have no increased risk of primary ovarian insufficiency, also known as premature menopause, according to a Kaiser Permanente study published today in Pediatrics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 21, 2018 Category: International Medicine & Public Health Source Type: news

HPV Legislation Doesn't Impact Teen Sexual Behaviors
WEDNESDAY, Aug. 15, 2018 -- Implementation of state legislation relating to human papillomavirus (HPV) vaccination is not associated with changes in adolescent sexual behaviors, according to a study published online Aug. 13 in Pediatrics. Erin E.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2018 Category: Pharmaceuticals Source Type: news

State HPV vaccine laws do not appear to influence teen sex
(Reuters Health) - State laws designed to increase teen vaccination against the cancer-causing human papillomavirus (HPV) don't appear to influence adolescents' choices about whether to become sexually active or use condoms, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Promoting HPV Vaccine Doesn't Prompt Risky Sex by Teens: Study
MONDAY, Aug. 13, 2018 -- Controversial state laws that promote vaccinating kids against the human papillomavirus (HPV) do not increase the likelihood that teens will engage in risky sexual behavior, a new study contends. " Parents and caregivers, as... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 13, 2018 Category: General Medicine Source Type: news

Get "versed" on the dangers of the highly experimental HPV vaccine before Merck brainwashes you or your children with propaganda
(Natural News) The manufacturers of one of the biggest vaccines scams ever created want your children and teenagers to think it’s hip to get injected with genetically modified organisms that have caused over 140 deaths and more than 10,000 adverse events, including loss of muscle use, seizures, and anaphylactic shock. Yes, we’re talking about Gardasil,... (Source: NaturalNews.com)
Source: NaturalNews.com - August 9, 2018 Category: Consumer Health News Source Type: news